V CompBrief BY VELARION

Independent Director · ALX ONCOLOGY HOLDINGS INC (ALXO)

Chris Takimoto, M.D., Ph.D., F.A.C.P — ALX ONCOLOGY Director Compensation (2025)

Fiscal year 2025 director compensation for Chris Takimoto, M.D., Ph.D., F.A.C.P at ALX ONCOLOGY HOLDINGS INC. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 20, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Chris Takimoto, M.D., Ph.D., F.A.C.P’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Chris Takimoto, M.D., Ph.D., F.A.C.P and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

ALX ONCOLOGY Director Compensation Table · the one fiscal year held
In US dollars, as ALX ONCOLOGY reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$47,419$0$51,445$0$98,864

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ALX ONCOLOGY HOLDINGS INC DEF 14A filed April 20, 2026, accession 0001193125-26-163936, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ALX ONCOLOGY HOLDINGS INC filed document, accession 0001193125-26-163936. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2026.

Get the ALX ONCOLOGY Board Governance Report

$98,864 Chris Takimoto, M.D., Ph.D., F.A.C.P, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 20, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

ALX ONCOLOGY pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Compensation

The rest of the ALX ONCOLOGY board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alan Sandler, M.DDirector$600,789
Corey Goodman, Ph.DChair of the Board$147,871
Daniel Curran, M.DIndependent Director$38,973
Rekha HemrajaniIndependent Director$115,011
Scott GarlandIndependent Director$113,511

The full ALX ONCOLOGY compensation record

free company brief
ALX ONCOLOGY HOLDINGS INC (ALXO) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within ALX ONCOLOGY's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the ALX ONCOLOGY proxy · each links to its own free brief

Order ALXO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report